Legend Biotech's total assets for Q1 2026 were $1.60B, a decrease of -7.90% from the previous quarter. LEGN total liabilities were $629.02M for the fiscal quarter, a -14.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.